For colorectal cancer, RARγ overexpression was linked to multidrug resistance with knockdown leading to downregulation of multi-drug resistance 1 and suppression of the Wnt/β-catenin pathway (Huang et al., 2017). The gene discussed is RARG; the disease is colorectal cancer.